DR   Wikidata; Q108820493
RX   PubMed=34535163;
CC   Problematic cell line: Contaminated. Parent cell line (HO-8910) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI:31355; Carboplatin (CBP; Paraplatin).
CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6868 ! HO-8910
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
RX   PubMed=34535163; DOI=10.1186/s13048-021-00873-2;
RA   Zhang J., Xie S.-H., Zhou L., Tang X.-Y., Guan X.-L., Deng M.-J.,
RA   Zheng H., Wang Y.-C., Lu R.-Q., Guo L.;
RT   "Up-regulation of GSTT1 in serous ovarian cancer associated with
RT   resistance to TAXOL / carboplatin.";
RL   J. Ovarian Res. 14:122.1-122.14(2021).